2026-05-08T17:20:36.266Z / 路透社
作者：亚斯明·阿布塔莱布和贾勒特·伦肖
2026年5月8日 美国东部时间下午5:20 更新于1小时前
美国食品药品监督管理局局长马蒂·马卡里2025年11月10日在华盛顿特区卫生与公众服务部的新闻发布会上发言。路透社/伊丽莎白·弗朗茨 购买授权，打开新标签页
5月8日（路透社）——据知情人士透露，白宫已批准解雇美国食品药品监督管理局局长马蒂·马卡里的计划，这可能是联邦卫生部门的又一次领导层变动。
《华尔街日报》周五早些时候率先报道了唐纳德·特朗普总统计划解雇马卡里的消息。
路透社伊朗简报通讯将为您带来伊朗局势的最新动态与分析，点击此处订阅。
两位白宫顾问消息人士称，目前解雇决定尚未最终敲定。第三位亲近白宫的消息人士表示，他们被告知这位FDA局长“任期已尽”，且特朗普已签字同意。
“特朗普总统组建了史上经验最丰富、人才最出众的政府，本届政府将继续致力于为美国人民取得更多历史性胜利，”白宫发言人库什·德赛说道。
负责监管FDA的美国卫生与公众服务部未立即置评。
马卡里离职传闻甚嚣尘上
过去一周，由于对药物审批、疫苗政策以及FDA处理堕胎药米非司酮事宜的争议性决策引发担忧，马卡里可能离职的传闻愈演愈烈。
在马卡里和卫生部长小罗伯特·肯尼迪的领导下，该机构已有数千名员工通过解雇和自愿离职的方式离开，包括负责新药审评的大型部门。
广告 · 滚动继续阅读
高层官员已相继离开美国疾病控制与预防中心、美国国立卫生研究院等机构。
马卡里是约翰·霍普金斯大学医学院的外科肿瘤学家，于去年3月获任命为FDA局长。他曾撰写过关于医疗成本以及他所称的现代医疗体系弊端的畅销书，也是肯尼迪支持的“让美国再次健康”运动的核心倡导者之一。
本报道由班加罗尔的帕德马纳班·安南塔恩、华盛顿特区的艾哈迈德·阿布勒内因、亚斯明·阿布塔莱布、博·埃里克森和贾勒特·伦肖采写；卡罗琳·休默、迪帕·巴宾顿和比尔·伯克罗特编辑
我们的准则：汤姆森路透社信任原则。
Trump plans to fire FDA chief Makary, sources say
2026-05-08T17:20:36.266Z / Reuters
By Yasmeen Abutaleb and Jarrett Renshaw
May 8, 2026 5:20 PM UTC Updated 1 hour ago
U.S. Food and Drug Administration Commissioner Marty Makary speaks during a press conference at the Department of Health and Human Services in Washington, D.C., U.S., November 10, 2025. REUTERS/Elizabeth Frantz Purchase Licensing Rights, opens new tab
May 8 (Reuters) – The White House signed off on a plan to fire U.S. Food and Drug Administration Commissioner Marty Makary, according to sources familiar with the matter, in what could be the next leadership change within the federal health department.
The Wall Street Journal earlier on Friday first reported that President Donald Trump planned to fire Makary.
The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.
Two of the sources, who are advisers to the White House, said a decision was not final. A third source close to the White House said they were told the FDA commissioner “is done” and that Trump signed off.
Advertisement · Scroll to continue
“President Trump has assembled the most experienced and talented administration in history, an administration that continues to focus on delivering more historic victories for the American people,” White House spokesman Kush Desai said.
The U.S. Department of Health and Human Services, which oversees the FDA, was not immediately available for comment.
REPORTS OF MAKARY’S EXIT CIRCULATING
Over the past week, reports of Makary’s potential exit have intensified over concerns tied to controversial decisions on drug approvals, vaccines and the FDA’s handling of the abortion pill mifepristone.
Under Makary and Health Secretary Robert F. Kennedy Jr., thousands of employees have left the agency through firings and voluntary departures, including at the large divisions overseeing reviews of new drugs.
Advertisement · Scroll to continue
Leading officials have left the Centers for Disease Control and Prevention, the National Institutes of Health and others.
Makary, a surgical oncologist at the Johns Hopkins University School of Medicine, was confirmed as FDA commissioner last March. He wrote bestselling books on healthcare costs and what he described as modern medicine’s failures, and has been one of the key advocates of the Make America Healthy Again movement backed by Kennedy.
Reporting by Padmanabhan Ananthan in Bengaluru and Ahmed Aboulenein, Yasmeen Abutaleb, Bo Erickson and Jarrett Renshaw in Washington D.C.; Editing by Caroline Humer, Deepa Babington and Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles.
发表回复